MicroRNA-124 links p53 to the NF-κB pathway in B-cell lymphomas (Q38881957)

7 September 2017

title

MicroRNA-124 links p53 to the NF-κB pathway in B-cell lymphomas (English)

1 reference

7 September 2017

0 references

1 reference

D Jeong

1

1 reference

7 September 2017

J Kim

2

1 reference

7 September 2017

J Nam

3

1 reference

7 September 2017

H Sun

4

1 reference

7 September 2017

Y-H Lee

5

1 reference

7 September 2017

T-J Lee

6

1 reference

7 September 2017

R C T Aguiar

7

1 reference

7 September 2017

S-W Kim

8

1 reference

7 September 2017

language of work or name

1 reference

27 April 2015

1 reference

7 September 2017

1 reference

7 September 2017

volume

29

1 reference

7 September 2017

issue

9

1 reference

7 September 2017

page(s)

1868-1874

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2015.101

7 September 2017

exact match

0 references

cites work

The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

Novel therapeutic agents for B-cell lymphoma: developing rational combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

Double-hit B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Pr

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

microRNA-124 inhibits migration and invasion by down-regulating ROCK1 in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

MiR-124 suppresses growth of human colorectal cancer by inhibiting STAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

Epigenetic inactivation of the miR-124-1 in haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

The p53 network: cellular and systemic DNA damage responses in aging and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

MicroRNAs in the p53 network: micromanagement of tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

Multifunctional roles of urokinase plasminogen activator (uPA) in cancer stemness and chemoresistance of pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

MicroRNA-124-mediated regulation of inhibitory member of apoptosis-stimulating protein of p53 family in experimental stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

MicroRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

Gene set enrichment analysis unveils the mechanism for the phosphodiesterase 4B control of glucocorticoid response in B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

MicroRNAs miR-125a and miR-125b constitutively activate the NF-κB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

Rational combined targeting of phosphodiesterase 4B and SYK in DLBCL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

A microRNA-mediated regulatory loop modulates NOTCH and MYC oncogenic signals in B- and T-cell malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

Definition of a consensus binding site for p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

The p53/microRNA network in cancer: experimental and bioinformatics approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

Expression of the NF-κB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.101

Hepatocyte nuclear factor 4α-nuclear factor-κB feedback circuit modulates liver cancer progression

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25915824

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/LEU.2015.101

1 reference

Dimensions Publication ID

7 September 2017

1028365289

0 references

1 reference